CS
Clay Shorrock
President of LineaRx, Inc., Chief Legal Officer, Exec. Director Business Development (APDN)
LineaRxTherapeutic Areas
LineaRx Pipeline
| Drug | Indication | Phase |
|---|---|---|
| LineaDNA for mRNA/IVT Templates | mRNA Vaccine & Therapeutic Production | Platform/Partnership |
| LineaDNA for DNA Vaccines | Prophylactic & Therapeutic Vaccination | Platform/Partnership |
| LineaDNA for Cell & Gene Therapies | Viral Vector & Gene Editing Component Production | Platform/Partnership |
| Linea™ IVT System | High-Purity mRNA Production | Platform/Product |
| LineaDNA for Monoclonal Antibodies | Antibody Development & Transient Expression | Platform/Partnership |
| LineaDNA for Personalized Medicine | Patient-Specific Therapies | Research/Platform |